 WALTHAM, Mass., Sept. 17, 2021 GLOBE NEWSWIRE -- Aerovate Therapeutics, Inc. Nasdaq: AVTE, a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, announced it has been added to the Russell 2000 Index, effective after the markets close today, following the recent Russell US Indexes annual reconstitution. 